US Bancorp’s Enzo Biochem, Inc. ENZ Stock Holding History

US Bancorp’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-620	Closed	-$3K	–	3710
2018 Q1	$3K	Hold	620	–	–	﹤0.01%	3443
2017 Q4	$5K	Sell	620 -740	-54%	-$7.07K	﹤0.01%	3334
2017 Q3	$14K	Buy	1,360 +615	+83%	+$6.83K	﹤0.01%	3010
2017 Q2	$8K	Hold	745	–	–	﹤0.01%	3119
2017 Q1	$6K	Hold	745	–	–	﹤0.01%	3173
2016 Q4	$5K	Hold	745	–	–	﹤0.01%	3202
2016 Q3	$4K	Hold	745	–	–	﹤0.01%	3222
2016 Q2	$4K	Hold	745	–	–	﹤0.01%	3249
2016 Q1	$3K	Hold	745	–	–	﹤0.01%	3314
2015 Q4	$3K	Sell	745 -525	-41%	-$2.22K	﹤0.01%	3376
2015 Q3	$4K	Hold	1,270	–	–	﹤0.01%	3310
2015 Q2	$4K	Buy	1,270 +840	+195%	+$2.36K	﹤0.01%	3345
2015 Q1	$1K	Sell	430 -37,245	-99%	-$122K	﹤0.01%	3505
2014 Q4	$167K	Sell	37,675 -3,870	-9%	-$18.5K	﹤0.01%	1856
2014 Q3	$214K	Buy	41,545 +1,400	+3%	+$7.47K	﹤0.01%	1715
2014 Q2	$211K	Sell	40,145 -3,540	-8%	-$15.3K	﹤0.01%	1777
2014 Q1	$182K	Buy	+43,685	New	+$150K	﹤0.01%	1825

Other funds holding ENZ

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

US Bancorp's ENZ Position: Q2 2018 in Review

US Bancorp sold out of Enzo Biochem, Inc. (ENZ) in Q2 2018, closing a stake of 620 shares — an estimated $3K sold.

US Bancorp first reported a position in ENZ in Q1 2014 and held it in 17 quarters. The position peaked at $214K in Q3 2014. 97 funds tracked by Wall St. Rank hold ENZ as of Q2 2018.

US Bancorp reported no remaining Enzo Biochem, Inc. position as of Q2 2018 after selling out during the quarter.
US Bancorp sold 620 Enzo Biochem, Inc. shares in Q2 2018, an estimated $3K.
US Bancorp first reported a position in Enzo Biochem, Inc. in Q1 2014 and held it in 17 quarters.
US Bancorp's Enzo Biochem, Inc. position peaked at $214K in Q3 2014.
97 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2018.

Based on US Bancorp's 13F filing for Q2 2018, filed 8 Aug 2018.